In this study, using five sets of variant TMAs, including colorectal, esophageal, liver, prostate, and breast cancers, we have found that PRSS8 expression was reduced in all of the five types of cancer tissues, and poorly differentiated cancers exhibited less or absent expression of PRSS8. This evidence concerns the gene PRSS8 and breast carcinoma.